Targovax ASA logo

TRVX - Targovax ASA News Story

NOK6.36 0.0  0.3%

Last Trade - 12:18pm

Sector
Healthcare
Size
Micro Cap
Market Cap £41.6m
Enterprise Value £35.8m
Revenue £221k
Position in Universe 1021st / 1792

BRIEF-Targovax Enters Collaboration With Oblique

Mon 29th June, 2020 6:08am
June 29 (Reuters) - Targovax ASA  TRVX.OL :
    * TARGOVAX AND OBLIQUE ENTER COLLABORATION TO TARGET MUTANT
RAS
CANCERS BY
    * TARGOVAX AND OBLIQUE WILL JOINTLY EXPLORE FEASIBILITY AND
ANTI-CANCER POTENTIAL OF MERGING THEIR ONCOS AND ABIPROT
TECHNOLOGY PLATFORMS
    * ONCOS WILL BE USED TO DELIVER ABIPROT ANTIBODIES AGAINST
HARD-TO-REACH TARGETS SUCH AS MUTANT RAS

Source text for Eikon:  ID:nObizSKx5a 
Further company coverage:  TRVX.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.